Medicare Part D Drug Price Policies May Offer Financial Trade-Offs

Higher manufacturer discounts required in donut hole under new budget law could offset somewhat by point-of-sale rebates in Part D, which are expected to be included in President Trump's FY 2019 budget proposal.

Glazed donuts or doughnuts set 3d rendering

A pair of Medicare Part D drug pricing measures emerging from Congress and the Administration could act as financial offsets to an extent in terms their impact on biopharma manufacturers.

Manufacturers face a substantial increase in the price discounts they are required to provide for drugs obtained by beneficiaries in...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Medicare

More from Government Payers